Anticoagulant Reversal Agents
On this page
Direct answer
Anticoagulant reversal agents are drugs that neutralise a specific anticoagulant during life-threatening bleeding, and the correct agent depends on the drug the patient has taken. Vitamin K reverses warfarin slowly, prothrombin complex concentrate acts quickly, protamine neutralises unfractionated heparin, and idarucizumab reverses dabigatran. Andexanet alfa is the specific option for factor Xa inhibitors where it is available.
What you must remember
- Vitamin K: phytonadione reverses warfarin over hours, so it is combined with a faster agent in major bleeding.
- Prothrombin complex concentrate: a four-factor product containing factors II, VII, IX and X that reverses warfarin rapidly, and is used off-label for factor Xa inhibitor bleeding in many centres.
- Protamine: binds unfractionated heparin and neutralises it; it only partially reverses low molecular weight heparin.
- Protamine adverse effects: hypotension, bronchospasm and anaphylaxis, with risk in fish allergy and in patients previously exposed to protamine or NPH insulin.
- Idarucizumab: a monoclonal antibody fragment that binds dabigatran specifically and reverses its effect.
- Andexanet alfa: a modified factor Xa decoy protein for rivaroxaban and apixaban; availability varies by country, and it was withdrawn from the US market in late 2025 over thrombotic-event concerns.
- Tranexamic acid: an antifibrinolytic adjunct that does not reverse anticoagulation, so the drug still has to be identified and reversed.
Matching the agent to the drug and the bleed
Reversal is reserved for major or life-threatening bleeding, because each agent carries a thrombotic risk. The sequence below starts with identifying the drug, since the right agent follows from it.
- Identify the anticoagulant. Warfarin is judged by INR, unfractionated heparin by APTT, and direct oral anticoagulants by drug-specific assays or the timing of the last dose.
- Judge the bleed. Major or life-threatening bleeding justifies rapid reversal, while minor bleeding is usually managed by stopping the drug and supporting the patient.
- Reverse warfarin. Vitamin K is given with prothrombin complex concentrate, and fresh frozen plasma is used only when concentrate is unavailable, since it needs a larger volume.
- Reverse heparin. Protamine is dosed against the heparin given recently, with the most recent doses counting most.
- Reverse dabigatran or factor Xa inhibitors. Idarucizumab reverses dabigatran, while factor Xa inhibitors are reversed with andexanet alfa where it is available, and otherwise with prothrombin complex concentrate.
- Support and monitor. Coagulation tests and haemoglobin are rechecked, volume is replaced, and the team watches for thrombosis after reversal.
Where the exam tries to catch you
Questions test whether the agent is matched to the drug, not chosen from habit.
- Trap: Fresh frozen plasma is the first choice to reverse warfarin. Correct: prothrombin complex concentrate acts faster in a smaller volume, so fresh frozen plasma is reserved for when concentrate is not available.
- Trap: Protamine reverses enoxaparin completely. Correct: protamine only partially neutralises low molecular weight heparin, and the answer should say partial reversal.
- Trap: Tranexamic acid reverses the anticoagulant. Correct: it is an adjunct that limits clot breakdown, and the anticoagulant itself still needs a specific reversal agent.
Frequently asked questions
Which agent reverses warfarin-induced major bleeding?
Prothrombin complex concentrate, given together with vitamin K, is the standard agent for major bleeding on warfarin. It restores factors II, VII, IX and X quickly, whereas vitamin K alone acts over hours.
How is unfractionated heparin reversed in an emergency?
Unfractionated heparin is reversed by protamine sulphate, which binds heparin and neutralises its effect. Protamine can cause hypotension, bronchospasm and anaphylaxis, especially in patients with fish allergy or prior exposure to protamine or NPH insulin.
Which agent specifically reverses dabigatran?
Idarucizumab is a monoclonal antibody fragment that binds dabigatran specifically and reverses its anticoagulant effect. It is the specific reversal agent for dabigatran-related bleeding, and its action is near-immediate, which suits emergencies.
What is andexanet alfa used for?
Andexanet alfa is a modified factor Xa decoy protein that binds factor Xa inhibitors such as rivaroxaban and apixaban. Its availability varies by country, with US withdrawal in late 2025 over thrombotic-event concerns, and prothrombin complex concentrate is used where it is not available.
Does tranexamic acid reverse anticoagulation?
Tranexamic acid does not reverse anticoagulation. It is an antifibrinolytic adjunct that limits clot breakdown, and the anticoagulant still needs identification and a specific reversal agent.